Isolation and identification of a sibutramine analogue adulterated in slimming dietary supplementsJI WON KIM; SOON JAE KWEON; WOO SEONG KIM et al.Food additives & contaminants. Part A. Chemistry, analysis, control, exposure & risk assessment (Print). 2013, Vol 30, Num 7, pp 1221-1229, issn 1944-0049, 9 p.Article

Determination of sibutramine with a new sensor based on luminol electrochemiluminescenceSHAOWEI WANG; JINGHUA YU; FUWEI WAN et al.Journal of luminescence. 2011, Vol 131, Num 7, pp 1515-1519, issn 0022-2313, 5 p.Article

Sibutramine : l'Agence européenne soumise aux firmes = Sibutramine : the European Agency subjected to the firmsLa Revue Prescrire. 2003, Vol 23, Num 236, issn 0247-7750, p. 111Article

Agreement between weekly vs. daily assessment of appetiteWOMBLE, Leslie G; WADDEN, Thomas A; CHANDLER, Julie M et al.Appetite (Print). 2003, Vol 40, Num 2, pp 131-135, issn 0195-6663, 5 p.Article

Development and Validation of a Column High-Performance Liquid Chromatographic Method for Determination of Sibutramine in CapsulesFRACAO DIEFENBACH, Isabel Cristina; FRIEDRICH, Milene; DOS SANTOS, Marcos Roberto et al.Journal of AOAC International. 2009, Vol 92, Num 1, pp 188-191, issn 1060-3271, 4 p.Article

Serotonin syndrome following sibutramine poisoning in a child, with sequential quantification of sibutramine and its primary and secondary amine metabolites in plasmaBUCARETCHI, Fabio; DE CAPITANI, Eduardo Mello; MOREIRA MELLO, Sueli et al.Clinical toxicology (Philadelphia, Pa. Print). 2009, Vol 47, Num 6, pp 598-601, issn 1556-3650, 4 p.Article

Locomotor and peripheral effects of sibutramine modulated by 5-HT₂ receptorsSORIANO FRASSETTO, Silvana; SANTA RUBIO, Angela Della; JARDIM LOPES, Janaina et al.Canadian journal of physiology and pharmacology. 2006, Vol 84, Num 12, pp 1239-1244, issn 0008-4212, 6 p.Article

New central targets for the treatment of obesity : ObesitySARGENT, Bruce J; MOORE, Nicholas A.British journal of clinical pharmacology. 2009, Vol 68, Num 6, issn 0306-5251, 852-860, 967 [10 p.]Article

Sibutramine in the treatment of antipsychotic-induced weight gain: a pilot study in patients with schizophreniaBIEDERMANN, Falko; FLEISCHHACKER, W. Wolfgang; KEMMLER, Georg et al.International clinical psychopharmacology. 2014, Vol 29, Num 3, pp 181-184, issn 0268-1315, 4 p.Article

Use of sibutramine to assist obese women with weight loss can be successful in dietitian-led clinics : another tool in the dietitian's toolboxBARRATT, R; FROST, G; O'BOYLE, A et al.Journal of human nutrition and dietetics (Print). 2008, Vol 21, Num 3, pp 248-255, issn 0952-3871, 8 p.Article

Short-term effects of sibutramine (Reductil) on appetite and eating behaviour and the long-term therapeutic outcomeBARKELING, B; ELFHAG, K; ROOTH, P et al.International journal of obesity. 2003, Vol 27, Num 6, pp 693-700, issn 0307-0565, 8 p.Article

Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trialsPADWAL, R; LI, S. K; LAU, D. C. W et al.International journal of obesity. 2003, Vol 27, Num 12, pp 1437-1446, issn 0307-0565, 10 p.Article

Effects of sibutramine alone and with alcohol on cognitive function in healthy volunteersWESNES, K. A; GARRATT, C; WICKENS, M et al.British journal of clinical pharmacology. 2000, Vol 49, Num 2, pp 110-117, issn 0306-5251Article

Sibutramine pharmacokinetics in young and elderly healthy subjectsHIND, I. D; MANGHAM, J. E; GHANI, S. P et al.European journal of clinical pharmacology. 1999, Vol 54, Num 11, pp 847-849, issn 0031-6970Article

Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 geneHSIAO, Dun-Jen; WU, Lawrence Shih-Hsin; HUANG, Shih-Yi et al.Pharmacogenetics and genomics (Print). 2009, Vol 19, Num 9, pp 730-733, issn 1744-6872, 4 p.Article

Crystal Chemistry of Sibutramine : Thermal, Diffractometric and Spectroscopic CharacterizationMACCARONI, Elisabetta; ALBERTI, Enrica; MALPEZZI, Luciana et al.Journal of pharmaceutical sciences. 2008, Vol 97, Num 12, pp 5229-5239, issn 0022-3549, 11 p.Article

Sibutramine use in pregnancy: Report of two casesKADIOGLU, Mine; ULKU, Cunay; YARIS, Fusun et al.Birth defects research. Clinical and molecular teratology. 2004, Vol 70, Num 8, pp 545-546, issn 1542-0752, 2 p.Article

Des médicaments pour traiter l'obésité : Pourquoi ? Quand ? Comment ? = Pharmacological treatment for obesity : When? Why? How?LAURENT-JACCARD, A.Médecine et hygiène. 1999, Vol 57, Num 2274, pp 2031-2033, issn 0025-6749Article

Proteome changes in rat plasma in response to sibutramineCHOI, Jung-Won; JEONG IN JOO; DONG HYUN KIM et al.Proteomics (Weinheim. Print). 2011, Vol 11, Num 7, pp 1300-1312, issn 1615-9853, 13 p.Article

Catatonia and psychosis associated with sibutramine : A case report and pathophysiologic correlationLEE, Jimmy; TEOH, Timothy; LEE, Tih-Shih et al.Journal of psychosomatic research. 2008, Vol 64, Num 1, pp 107-109, issn 0022-3999, 3 p.Article

Development and Validation of Sensitive Methods for Determination of Sibutramine Hydrochloride Monohydrate and Direct Enantiomeric Separation on a Protein-Based Chiral Stationary PhaseANIL KUMAR SINGH; LOPEZ GARCIA, Pedro; PEREIRA GOMES, Fabio et al.Journal of AOAC International. 2008, Vol 91, Num 3, pp 572-579, issn 1060-3271, 8 p.Article

Sibutramine : Un bilan australien = Sibutramine : Four years experience in AustraliaLa Revue Prescrire. 2006, Vol 26, Num 277, pp 748-748, issn 0247-7750, 1 p.Article

Sibutramine : a review of clinical efficacyLEAN, M. E. J.International journal of obesity. Supplement. 1997, Vol 21, Num 1, pp S30-S36, issn 1359-6373Conference Paper

Sibutramine induces potential-dependent exocytotic release but not carrier-mediated release of dopamine and 5-hydroxytryptamineUKAI, Kiyoharu; NAKAGAWA, Terutake; OHYAMA, Tadashi et al.European journal of pharmacology. 2004, Vol 484, Num 2-3, pp 209-215, issn 0014-2999, 7 p.Article

Troubles cardiaques et sibutramine = Cardiac troubles and sibutramineLa Revue Prescrire. 2002, Vol 22, Num 227, issn 0247-7750, p. 275Article